Here, EVI1 expression was found to be downregulated following knockdown of CEBPA in inv(3) AML cells, and mutation of the CEBPA binding site in the hijacked enhancer reduced enhancer activity58. This evidence concerns the gene CEBPA and acute myeloid leukemia.